← Product Code [MCW](/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices/MCW) · K973669 # THROMBOLYTIC BRUSH CATHETER, OVER THE WIRE (OTW) (K973669) _Micro Therapeutics, Inc. · MCW · Feb 6, 1998 · Cardiovascular · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices/MCW/K973669 ## Device Facts - **Applicant:** Micro Therapeutics, Inc. - **Product Code:** [MCW](/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices/MCW.md) - **Decision Date:** Feb 6, 1998 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 870.4875 - **Device Class:** Class 2 - **Review Panel:** Cardiovascular - **Attributes:** Therapeutic ## Indications for Use The Micro Therapeutics, Inc. Over the Wire (OTW) Thrombolytic Brush Catheter is intended for percutaneous dissolution of acute thrombus (i.e., less than two weeks old) located in arteriovenous (A-V) fistula utilizing a .035" guide wire for tracking and positioning within the fistula. The OTW Thrombolytic Brush Catheter is designed to augment the area of interface between clot and pharmacologic augment by simultaneous thrombolysis and clot maceration. Clinical studies demonstrate effective dissolution of thrombus in A-V grafts when this product is used in conjunction with urokinase. The OTW Thrombolytic Brush Catheter is not intended for use in native vessels. The device should not be used on patients with a history of significant pulmonary disease or pulmonary hypertension. ## Device Story Device is a percutaneous catheter system for dissolving acute thrombus in A-V fistulas. System includes catheter with proximal Y-connector, distal soft brush on hollow drive shaft, and hand-held battery-powered motor drive. Operates by simultaneous mechanical clot maceration and infusion of pharmacologic agents (e.g., urokinase) to increase clot-drug interface. Used by clinicians in clinical settings. Device tracks over .035" guidewire. Output is physical dissolution of thrombus, aiding in graft patency restoration. Benefits include effective thrombus removal in A-V grafts. ## Clinical Evidence Evidence includes physical bench testing and in vivo animal studies. Bench testing evaluated dimensions, cable strength, motor integrity, flow rates, and electrical safety. Animal studies compared performance to predicate device for thrombus dissolution in A-V fistulas. No human clinical trial data reported. ## Technological Characteristics System comprises a catheter with proximal Y-connector, distal soft brush, and battery-powered motor drive. Materials tested per ISO 10993-1. Operates via mechanical maceration combined with pharmacologic infusion. Compatible with .035" guidewires. ## Regulatory Identification An intraluminal artery stripper is a device used to perform an endarterectomy (removal of plaque deposits from arterisclerotic arteries.) ## Predicate Devices - Thrombolytic Brush Catheter ([K963925](/device/K963925.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K973664 Image /page/0/Picture/2 description: The image shows the logo for Micro Therapeutics, Inc. The logo consists of the letters "MTI" in a bold, stylized font, with a series of small squares arranged in a grid pattern to the left of the letters. To the right of the letters is the full name of the company, "MICRO THERAPEUTICS, INC.", in a smaller, but still legible, font. 1062-F Calle Negocio San Clemente, CA 92673 Tel. 714-361- 0616 Fax 714- 361-0210 # 510(k) SUMMARY ## Contact Person Jack Gehrich Vice President of Regulatory & Clinical Affairs ### Trade Name Over the Wire (OTW) Thrombolytic Brush Catheter ## Common Name Thrombectomy Catheter Infusion Catheter ### Classification Name Percutaneous Catheter (per 21 CFR 870.1250) ## Substantially Equivalent Devices Thrombolytic Brush Catheter (Micro Therapeutics) ### Description The Micro Therapeutics, Inc. Over the Wire (OTW) Thrombolytic Brush Catheter is intended for the percutaneous dissolution of acute thrombus located in artificial The OTW Thrombolytic Brush Catheter is designed to arteriovenous (A-V) fistula. augment the area of interface between clot and pharmacologic agent by simultaneous thrombolysis and clot maceration. The integral system utilizes a catheter with proximal Yconnector, a soft brush attached at the distal end of a hollow drive shaft, and a hand-held battery-powered motor drive. ### Intended Use The Micro Therapeutics, Inc. Over the Wire (OTW) Thrombolytic Brush Catheter is intended for percutaneous dissolution of acute thrombus (i.e., less than two weeks old) located in arteriovenous (A-V) fistula utilizing a .035" guide wire for tracking and positioning within the fistula. The OTW Thrombolytic Brush Catheter is designed to augment the area of interface between clot and pharmacologic augment by simultaneous thrombolysis and clot maceration. Clinical studies demonstrate effective dissolution of thrombus in A-V grafts when this product is used in conjunction with urokinase. The OTW Thrombolytic Brush Catheter is not intended for use in native vessels. The device should not be used on patients with a history of significant pulmonary disease or pulmonary hypertension. 00046 {1}------------------------------------------------ # 510(k) SUMMARY (cont.) # Technological Characteristics This product is equivalent in intended use, as well as dimensional characteristics, composition and function to the legally marketed Thrombolytic Brush Catheter, (K963925) manufactured by Micro Therapeutics, Inc. # Summary of Studies ### Performance Data ### In Vitro Tests Sample sterile devices were subjected to extensive physical bench testing. In vitro tests were conducted which included dimensional measurements, bristle and wire cable strength characterization, motor drive integrity testing, catheter flow rates, bond strengths, burst pressure and performance under simulated conditions. Additionally, electromagnetic and patient safety tests were conducted by an independent laboratory to evaluate the electromagnetic and leakage current potential of the battery operated motor drive handle. Based on the results from these tests, it was concluded that the design performed equivalently to the predicate device and is suitable for its intended use. #### In Vivo Tests In vivo animal tests were performed to assess the performance of the Micro Therapeutics, Inc. Over the Wire (OTW) Thrombolytic Brush Catheter to that of a predicate device. The animal studies demonstrated that the OTW Thrombolytic Brush Catheter performed the same as the predicate device for percutaneous administration of pharmacologicals for dissolution of thrombus located in A-V fistulas. ## Biocompatibility Tests All components tested per ISO 10993-1. Conclusion: The Micro Therapeutics, Inc. Over the Wire (OTW) Thrombolytic Brush Catheter is substantially equivalent to the predicate device based on the results of laboratory and animal testing. 00047 {2}------------------------------------------------ Image /page/2/Picture/2 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal features a stylized eagle with its wings spread, symbolizing protection and service. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the eagle. The seal is simple and monochromatic. Rockville MD 20857 FEB - 6 1998 Mr. Brian Strauss Project Engineer Micro Therapeutics, Inc. 1062-F Calle Negocio San Clemente, CA 92673 K973669 Re: Over-the-Wire (OTW) Thrombolytic Brush Catheter Regulatory Class: II (two) Product Code: 74 MCW Dated: January 7, 1998 Received: January 9, 1998 Dear Mr. Strauss: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 A substantially equivalent determination assumes compliance to 895. with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS-inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {3}------------------------------------------------ This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ 510(k) Number: K973669 Device Name: Micro Therapeutics Over the Wire (OTW) Thrombolytic Brush Catheter Indications for Use: The Micro Therapeutics, Inc. Over the Wire (OTW) Thrombolytic Brush Catheter is intended for percutaneous dissolution of acute thrombus located in arteriovenous (A-V) fistula. The Over the Wire (OTW) Thrombolytic Brush Catheter is designed to augment the area of interface between clot and pharmacologic augment by simultaneous thrombolysis and clot maceration. Clinical studies demonstrate effective dissolution of thrombus in A-V grafts when this product is used in conjunction with urokinase. The Over the Wire (OTW) Thrombolytic Brush Catheter is not intended for use in native vessels. The device should not be used on patients with a history of significant pulmonary disease of pulmonary hypertension. If Micro Therapeutics, Inc. intends to recommend its Over the Wire (OTW) Thrombolytic Brush Catheter interface with specific pharmacological agents, Micro Micro Therapeutics will notify the Food and Drug Administration. Therapeutics, Inc. will not promote any such action until the Food and Drug Administration has reviewed and approved such action. Administration has re Th of th (Division Sign-Off) Division of Cardiovascular. Respiratory. and Neurological Devic 510(k) Number _ (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) **Prescription Use** (Per 21 CFR 801.109) ✓ OR Over the Counter Use 000491 --- **Source:** [https://fda.innolitics.com/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices/MCW/K973669](https://fda.innolitics.com/submissions/CV/subpart-e%E2%80%94cardiovascular-surgical-devices/MCW/K973669) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com